These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 21665226)

  • 1. Treatment with rtPA of stroke associated with intravenous immunoglobulins perfusion.
    Fonseca AC; Geraldes R; Almeida V; Pinho e Melo T
    J Neurol Sci; 2011 Sep; 308(1-2):180-1. PubMed ID: 21665226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
    Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytes may have 2 opposing effects in intravenous rtPA treatment for ischemic stroke.
    Nomura E; Naka H; Wakabayashi S; Kajikawa H; Matsumoto M
    Clin Appl Thromb Hemost; 2014 Jan; 20(1):37-42. PubMed ID: 22790658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue therapy with local intra-arterial urokinase after poor clinical response with intravenous recombinant tissue plasminogen activator in acute ischaemic stroke.
    Lee LH; Chryssidis S; Jannes J
    Intern Med J; 2011 Jul; 41(7):570-3. PubMed ID: 21762336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
    Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator (rtPA) for stroke. The perspective at 8 years.
    Frey JL
    Neurologist; 2005 Mar; 11(2):123-33. PubMed ID: 15733334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians.
    Leira EC; Pary JK; Davis PH; Grimsman KJ; Adams HP
    Arch Neurol; 2007 Apr; 64(4):518-21. PubMed ID: 17420312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
    Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Neuroimaging; 2011 Apr; 21(2):113-20. PubMed ID: 19909396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early neurological deterioration following intravenous recombinant tissue plasminogen activator therapy in patients with acute lacunar stroke.
    Hwang YH; Seo JG; Lee HW; Park SP; Suh CK
    Cerebrovasc Dis; 2008; 26(4):355-9. PubMed ID: 18728362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of stroke patients aged >80 years receiving intravenous rt-PA.
    Jauss M; Allendorfer J; Stolz E; Schutz HJ; Misselwitz B
    Cerebrovasc Dis; 2007; 24(2-3):305-6. PubMed ID: 17646696
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke.
    Perini F; De Boni A; Marcon M; Bolgan I; Pellizzari M; Dionisio LD
    J Neurol Sci; 2010 Oct; 297(1-2):52-4. PubMed ID: 20674932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue plasminogen activator for acute ischemic stroke.
    Al-Buhairi AR; Jan MM
    Saudi Med J; 2002 Jan; 23(1):13-9. PubMed ID: 11938357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.